The Silence in Hoch et al.’s Commentary about the Rationale for and Objective(s) of Canada’s Separate HTA Process for Cancer Drugs: The Importance of Transparency and Accountability when Allocating Taxpayers’ Dollars Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 2015
has subject area
- 11 Medical and Health Sciences (FoR)
- 14 Economics (FoR)
- Antineoplastic Agents (MeSH)
- Canada (MeSH)
- Disclosure (MeSH)
- Health Policy & Services (Science Metrix)
- Humans (MeSH)
- Neoplasms (MeSH)
- Resource Allocation (MeSH)
- Social Responsibility (MeSH)
- Taxes (MeSH)
- Technology Assessment, Biomedical (MeSH)
published in
- PharmacoEconomics (Auckland) Journal